AKT3 and hepatocellular carcinoma: miR-424-5p, which was reported to affect growth through inhibiting Akt3 and E2F348, was down-regulated in tumor tissues and its expression levels in HCC tissues correlated with tumor size, multiple nodules, tumor stage and overall survival outcome.